ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PHAR Pharming Group NV

7.65
0.12 (1.59%)
26 Nov 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Pharming Group NV NASDAQ:PHAR NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.12 1.59% 7.65 3.84 30.00 7.95 7.64 7.85 9,940 01:00:00

Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023

13/04/2023 12:11pm

PR Newswire (US)


Pharming Group NV (NASDAQ:PHAR)
Historical Stock Chart


From Nov 2022 to Nov 2024

Click Here for more Pharming Group NV Charts.

LEIDEN, Netherlands, April 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that Pharming's management will attend the 22nd Annual Needham Virtual Healthcare Conference April 17 - 20, 2023.

Pharming_Group_Logo

Pharming's CEO, Sijmen de Vries, will present on April 20 at 08:00 ET /14:00 CEST.

A live webcast and replay of the presentation can be found in the "Upcoming Events" and "News" sections of Pharming's website.

Pharming's management will be available for one-to-one investor meetings during the conference.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your Needham representative, or send an email to Pharming's Investor Relations team to investor@pharming.com.

About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696

Heather Robertson, Investor Relations & Corporate Communications Manager
E: investor@pharming.com 

FTI Consulting, London, UK 
Victoria Foster Mitchell/Alex Shaw/Amy Byrne 
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands 
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Logo - https://mma.prnewswire.com/media/2003587/Pharming_Group_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pharming-to-present-at-the-22nd-annual-needham-virtual-healthcare-conference-2023-301796648.html

Copyright 2023 PR Newswire

1 Year Pharming Group NV Chart

1 Year Pharming Group NV Chart

1 Month Pharming Group NV Chart

1 Month Pharming Group NV Chart

Your Recent History

Delayed Upgrade Clock